The snake-venom thrombin-like enzymes (SVTLEs) are a class of serine proteinases that show fibrinogen-clotting and esterolytic activities. Most TLEs convert fibrinogen to fibrin by releasing either fibrinopeptide A or fibrinopeptide B and cannot activate factor XIII. The enzymes hydrolyze fibrinogen to produce non-cross-linked fibrins, which are susceptible to the lytic action of plasmin. Because of these physiological properties, TLEs have important medical applications in myocardial infarction, ischaemic stroke and thrombotic diseases. Here, a three-step chromatography procedure was used to purify saxthrombin (AAP20638) from Gloydius saxatilis venom to homogeneity. Its molecular weight is about 30 kDa as estimated by SDS-PAGE. A saxthrombin crystal was obtained using the hanging-drop vapour-diffusion method and diffracted to a resolution limit of 1.43 Å . The crystal belongs to space group C2, with unit-cell parameters a = 97.23, b = 52.21, c = 50.10 Å , = 96.72 , and the Matthews coefficient (V M ) was calculated to be 2.13 Å 3 Da À1 with one molecule in the asymmetric unit.
Introduction
Snake venoms are mixtures of numerous proteins with enzymatic or toxic activities. The proteolytic enzymes contained in snake venoms affect the host coagulation process in various ways. These enzymes include the snake-venom thrombin-like enzymes (SVTLEs), which are distributed in several snake genera (Castro et al., 2004) . SVTLEs are serine proteinases and resemble thrombin in their ability to catalyze the last of the highly substrate-specific proteolytic reactions in the coagulation process.
Thrombin converts soluble fibrinogen to insoluble fibrin by proteolytic release of both fibrinopeptide A and fibrinopeptide B from the N-terminal disulfide knot of the fibrinogen A and B chains. Although TLEs also lead to clotting by hydrolysis of fibrinogen, there are many differences compared with thrombin. For instance, most SVTLEs only release one of the fibrinopeptides, mostly fibrinopeptide A, with the exception of a few TLEs such as jararacussin from Bothrops jararacussu venom (Castro et al., 2004) . In addition, TLEs cannot activate factor XIII, an important zymogen that is activated by thrombin. TLEs have some deletions in their primary structure in regions around the active-site cleft that allow the large substrate side chain to gain access to the base of the thrombin catalytic site. These changes may explain the differences in the function of TLEs compared with thrombin.
The unconventional polymers formed by TLEs cannot be identified by the coagulation cascade factor and these non-cross-linked fibrins are more susceptible to clearance by the lytic action of plasmin than the cross-linked fibrins formed by thrombin (Furukawa & Ishimaru, 1990) . Because the non-cross-linked fibrins formed by TLEs are quickly degraded and cleaned away in the bloodstream, the thrombin-like enzymes have considerable clinical application in the treatment of various thrombo-embolic states and in the prevention of thrombosis (Huang et al., 1999) . Since the gene for batroxobin from B. atrox moojeni venom was isolated and analyzed (Itoh et al., 1987) , many other thrombin-like enzymes have been thoroughly studied and several SVTLEs have been isolated and sequenced (Furukawa & Ishimaru, 1990) .
Gloydius saxatilis is one of the most toxic snakes in the north of China and its venom affects platelet function and the bloodcoagulation process in many ways. Sun et al. (2003) purified TLEs from G. saxatilis and used RT-PCR to amplify the cDNA of the gene in the venom gland of G. saxatilis. They determined a nucleotide sequence (AAP20638) that codes for a pre-zymogen protein of 258 amino acids with a predicted molecular weight of 29.8 kDa. Aminoacid sequence comparisons showed that it had a high identity to thrombin-like enzymes from other snakes (Sun et al., 2003) .
Materials and methods

Materials
Crude G. saxatilis venom was obtained from the Institute of Snakes and Snake Venoms of the Dalian Shedao Hospital (Dalian, People's Republic of China). DEAE-Sepharose, Phenyl-Sepharose and CM-Sepharose were purchased from Pharmacia (Sweden). The Crystal Screen kit was purchased from Hampton Research (USA). p-Toluenesulfonyl-l-arginine methyl ester (TAME) and bovine fibrinogen were purchased from Sigma (USA). Other reagents and chemicals of analytical grade were produced by Shanghai Biochemical Technology Co. (People's Republic of China).
Purification
Saxthrombin was purified from G. saxatilis venom by a three-step chromatography procedure as follows (see Fig. 1 ). Firstly, 1.4 g crude venom was dissolved in 15 ml loading buffer A (20 mM Tris-HCl pH 8.2) and centrifuged at 14 000 rev min À1 for 20 min. The supernatant was applied onto a DEAE-Sepharose Fast Flow column preequilibrated with loading buffer A. The column was washed with loading buffer A and then eluted with a 0.0-0.4 M linear NaCl gradient at a flow rate of 150 ml h À1 . All fractions were collected and individually analyzed for clotting activity using bovine fibrinogen. Peak 3, which had the greatest activity, was pooled. The peak 3 sample was dialyzed against loading buffer B (1.5 M ammonium sulfate, 50 mM Tris-HCl pH 7.5) and applied onto a Phenyl-Sepharose column, followed by elution with 400 ml of a linear ammonium sulfate gradient from 1.5 to 0 M. Peaks 3 and 4 were pooled and dialyzed against loading buffer C (20 mM sodium acetate/ acetic acid pH 4.4). The pooled sample was concentrated and applied crystallization communications onto a CM-Sepharose Fast Flow column pre-equilibrated with loading buffer C. The column was eluted with 300 ml of a linear NaCl gradient from 0.0 to 0.2 M. Peak 1 was pooled, concentrated and desalted. Saxthrombin was purified to high homogeneity and its molecular weight was approximately 30 kDa as estimated by SDS-PAGE, which is close to the predicted weight.
Enzyme assays
We used the method of Hahn et al. (1996) to measure the clotting activity of saxthrombin. The clotting activity was assayed at 310 K using 4 mg ml À1 bovine fibrinogen in 0.3 ml 50 mM Tris-HCl buffer pH 7.5 containing 0.9%(w/v) NaCl by recording the time required for the formation of clots after addition of the enzyme. The clots were observed at 310 K for several hours in order to investigate their stability.
The arginine esterase activity of saxthrombin was measured using the method of Nolan et al. (1976) . The enzyme activity was assayed using TAME as a substrate. 0.5 mg purified enzyme was added to glass tubes containing 300 ml 0.5 mM TAME in 50 mM Tris-HCl pH 8.0 and 0.1% methanol. After thorough mixing, the increase in the absorbance at 247 nm was measured for 10 min at 293 K. One unit of TAME activity was defined as the amount of enzyme catalyzing the hydrolysis of 1 mmol of TAME per minute.
Crystallization
Crystallization experiments were performed at 293 K by the hanging-drop vapour-diffusion method, using Hampton Research Crystal Screens to screen for initial crystallization conditions. The protein was dissolved in 5 mM Tris-HCl pH 8.5 and its concentration was estimated to be 22 mg ml À1 using the Bradford assay. Microcrystals formed in conditions No. 46 and No. 95 of the Crystal Screen kit. Optimized crystals based on condition No. 46 were obtained by mixing 2 ml protein solution with 2 ml modified reservoir solution [containing 0.25 M calcium acetate, 0.1 M sodium cacodylate pH 6.5 and 16%(w/v) polyethylene glycol 8000] and then equilibrating against 300 ml reservoir solution. Two weeks later, a crystal of approximate dimensions 0.6 Â 0.4 Â 0.4 mm appeared (Fig. 2) .
X-ray diffraction analysis and structure determination
All diffraction data were measured using a crystal cryoprotected in 0.20 M calcium acetate, 0.08 M sodium cacodylate pH 6.5, 12%(w/v) PEG 8000 and 20% glycerol. The crystal was directly flash-cooled in a stream of cold nitrogen gas at 105 K using an Oxford Cryosystems cooling device (Oxford Cryosystems Ltd, UK). X-ray diffraction data were collected using a MAR345 imaging-plate detector (MAR Research, Germany) with double-mirror focused Cu K X-rays produced by a Rigaku RA-Micro007 rotating-anode generator. The oscillation angle was 1.0 and the exposure time was 10 min per frame. A total of 257 diffraction images were recorded from one crystal at a camera distance of 80 mm and the data were processed using HKL-2000 (Otwinowski & Minor, 1997) . The data-collection and processing statistics are listed in Table 1 .
Results and discussion
Because the insoluble fibrin clots formed after intravenous injection of TLEs can rapidly be removed from the blood circulation, TLEs have been used in prevention of the formation of thrombi and in the reduction of blood viscosity. For these reasons, TLEs are purified on a large scale and are being commercially produced as clinical drugs. Here, we purified saxthrombin from G. saxatilis to homogeneity as evidenced by the single band on SDS-PAGE. The purified enzyme efficiently cleaves TAME with an arginine esterase activity of 2 554 U mg À1 .
Saxthrombin was crystallized in space group C2, with unit-cell parameters a = 97.23, b = 52.21, c = 50.10 Å , = 96.72 . There is one molecule per asymmetric unit based on the Matthews coefficient (V M ) of 2.13 Å 3 Da À1 , which corresponds to 42.4% solvent content. This TLE from G. saxatilis shares 86% amino-acid sequence identity with AaV-SP-I, a snake-venom serine proteinase from Agkistrodon acutus for which the structure has been solved (PDB code 1op0). Using this structure as a model, the phase problem was solved by molecular replacement. It is expected that our high-resolution structure will help us to understand the differences of this enzyme from thrombin and assist in thrombotic medicine research in the future.
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Figure 2
Crystal of saxthrombin.
